Detecting Cancer Early Research Priorities Survey
Between December 2018 – February 2019 we ran a consultation to identify under-researched topics in cancer research that could help detect the disease sooner.
The survey asked adult patients, their families, carers and health professionals for their ideas on how early detection could be improved, which we aim to develop into a final top 10 research priorities later in 2019.
We are now moving on to the next phase of research, however, if you still wish to share your views you access the survey below:
Next steps and taking part
In the coming months we’ll be sharing feedback and responses from the initial survey, where you’ll also have the chance to rank questions by how important they are to you.
This ‘long list’ of questions will then go to a workshop in June, where we’re inviting patients, families and professionals along to help draw up our final top 10 priorities.
The workshop will take place on Wednesday 4 September, 10am – 4pm at The University of Manchester.
Bookings will open in the coming months but you can express your interest by getting in touch via the email below.
Stay up-to-date and get in touch
This page will be regularly as our research progresses. You can also follow updates on Twitter @EarlyPSP.
Alternatively, please contact:
Dr Ellena Badrick
Survey Project Manager & Cancer Data Scientist
0161 918 2349
Further information about this research
Almost 360,000 people in the UK are diagnosed with cancer every year*. Detecting cancer as early as possible is critical to patients getting the most effective treatment.
The aim of the Detecting Cancer Early Research Priorities Survey to gather unanswered research questions on detecting cancer early and generate a top 10 set of priorities to inform future research in this area.
It uses a Priority Setting Partnership (PSP) methodology from the internationally recognised James Lind Alliance. A PSP aims to bring together patients, carers and healthcare professionals to jointly identify priorities for research.
The project steering group comprises patient representatives, researchers and healthcare professionals. It has been approved by The University of Manchester’s Research Ethics Committee (reference number: 2018-4400-7542).
*2001 – 2015 incidence figures compiled for each nation from Office for National Statistics, ISD Scotland, Welsh Cancer Intelligence and Surveillance Unit and Northern Ireland Cancer Registry.